Regulation of SirT1 by Deleted in Breast Cancer 1 (DBC1)
Regulation of SirT1 by Deleted in Breast Cancer 1 (DBC1)
批准号:
8206714
负责人:
Zhenkun Lou
金额:
$30.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-01-01 至 2013-12-31
关键词:
8p21AffectAffinity ChromatographyAgingApoptosisApoptoticBRCA1 geneBiological ProcessCancer cell lineCarcinogensCell SurvivalCell physiologyCellular Stress ResponseDNA DamageDeacetylaseDown-RegulationEnergy MetabolismHealthInhibition of ApoptosisKIAA1967 geneKnockout MiceLightLinkLongevityMalignant NeoplasmsMalignant neoplasm of lungMammalian CellMass Spectrum AnalysisMolecularMusOrthologous GenePeroxisome Proliferator-Activated ReceptorsPhosphorylationPhosphorylation SitePhysiologicalProteinsRegulationRoleSignal PathwayYeastsage effectanti agingbasebiological adaptation to stresscell growthinsightmalignant breast neoplasmneoplastic cellresponsetranscription factortumortumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): SirT1, the mammalian ortholog of yeast Sir2, regulates a variety of cellular processes in mammalian cells, such as cellular stress response and energy metabolism, contributing to possible anti-aging effects. On the other hand, SirT1 activity is also important for tumor cell growth and survival, possibly due to SirT1's anti- apoptotic effect. Therefore, SirT1 has important implications in both aging and cancer, making SirT1 activity a double-edged sword that requires tight regulation. However, the regulation of SirT1 is unclear. In order to understand the regulation of SirT1, we set out to identify SirT1-associated proteins. Through tandem affinity purification and mass spectrum analysis, we have identified deleted in breast cancer-1 (DBC1) as a SirT1- associated protein. The DBC1 gene localizes to a region (8p21) that is frequently deleted in breast cancers; and loss of DBC1 expression has been detected in some breast and lung cancer cell lines. However, the causal relationship between loss of DBC1 and tumorigenesis has not been established. The cellular functions of DBC1 protein are also unclear. Our preliminary results suggest that DBC1 directly interacts with SirT1 and inhibits SirT1 activity. Downregulation of DBC1 potentiates SirT1-dependent inhibition of apoptosis in response to DNA damage. In addition, loss of DBC1 promotes tumorigenesis in the presence of carcinogens. Based on these observations, we hypothesize that DBC1 negatively regulates SirT1, thereby affecting DNA damage response, aging and tumorigenesis. To build on our previous observations, we now propose the following specific aims: 1. Investigate SirT1-dependent and SirT1-independent function of DBC1. 2. Investigate the regulation of SirT1-DBC1 interaction following DNA damage. 3. Use DBC1 knockout mice to explore the physiological role of DBC1 in aging and tumorigenesis. Results from these studies will not only shed new light on the regulation of SirT1, but also provide important insight into the molecular mechanisms of aging and cancer. PUBLIC HEALTH RELEVANCE: The protein deacetylase SirT1 is linked to both aging and cancer. However, the regulation of SirT1 is unclear. We will investigate the regulation of SirT1 by DBC1, which will provide important insights into the molecular mechanism of aging and cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ATR: targeting mechanical stress induced EMT and immune suppression in triple negative breast cancer
-
批准号:10658429
-
项目类别:
-
资助金额:$36.92万
-
财政年份:2023
-
负责人:Zhenkun Lou
-
依托单位:
Sensitizing Ovarian Cancer To PARP inhibitor and platinum treatment
-
批准号:10305524
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2021
-
负责人:Zhenkun Lou
-
依托单位:
Sensitizing Ovarian Cancer To PARP inhibitor and platinum treatment
-
批准号:10415197
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2021
-
负责人:Zhenkun Lou
-
依托单位:
Sensitizing Ovarian Cancer To PARP inhibitor and platinum treatment
-
批准号:10610944
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2021
-
负责人:Zhenkun Lou
-
依托单位:
The role of nuclear PD-L1 in breast tumor cell division, progression and therapy response
-
批准号:10553119
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2020
-
负责人:Zhenkun Lou
-
依托单位:
The role of nuclear PD-L1 in breast tumor cell division, progression and therapy response
-
批准号:10361225
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2020
-
负责人:Zhenkun Lou
-
依托单位:
The role of nuclear PD-L1 in breast tumor cell division, progression and therapy response
-
批准号:9897018
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2020
-
负责人:Zhenkun Lou
-
依托单位:
Regulation of Necroptosis and inflammation
-
批准号:10534748
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2019
-
负责人:Zhenkun Lou
-
依托单位:
Regulation of Necroptosis and inflammation
-
批准号:10316176
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2019
-
负责人:Zhenkun Lou
-
依托单位:
UFM1 signaling in DNA damage response and cancer therapy
-
批准号:10304188
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2017
-
负责人:Zhenkun Lou
-
依托单位:
UFM1 signaling in DNA damage response and cancer therapy
-
批准号:10057359
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2017
-
负责人:Zhenkun Lou
-
依托单位:
UFM1 signaling in DNA damage response and cancer therapy
-
批准号:9406523
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2017
-
负责人:Zhenkun Lou
-
依托单位:
Regulation of homologous recombination and cancer cell response to chemoradiotherapy
-
批准号:9055788
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2015
-
负责人:Zhenkun Lou
-
依托单位:
The Role of WSB1 in Tumorigenesis
-
批准号:9125795
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2014
-
负责人:Zhenkun Lou
-
依托单位:
The Role of WSB1 in Tumorigenesis
-
批准号:9330110
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2014
-
负责人:Zhenkun Lou
-
依托单位:
The Role of WSB1 in Tumorigenesis
-
批准号:8786949
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2014
-
负责人:Zhenkun Lou
-
依托单位:
Regultion of p53 Deubiquitination
-
批准号:8206756
-
项目类别:
-
资助金额:$32.72万
-
财政年份:2011
-
负责人:Zhenkun Lou
-
依托单位:
Regultion of p53 Deubiquitination
-
批准号:8775203
-
项目类别:
-
资助金额:$32.72万
-
财政年份:2011
-
负责人:Zhenkun Lou
-
依托单位:
Regultion of p53 Deubiquitination
-
批准号:8588904
-
项目类别:
-
资助金额:$31.74万
-
财政年份:2011
-
负责人:Zhenkun Lou
-
依托单位:
Regultion of p53 Deubiquitination
-
批准号:8408814
-
项目类别:
-
资助金额:$30.76万
-
财政年份:2011
-
负责人:Zhenkun Lou
-
依托单位:
海外基金